BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37311461)

  • 1. An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation.
    Yiu SPT; Zerbe C; Vanderwall D; Huttlin EL; Weekes MP; Gewurz BE
    Mol Cell; 2023 Jul; 83(13):2367-2386.e15. PubMed ID: 37311461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.
    Fares S; Spiess K; Olesen ETB; Zuo J; Jackson S; Kledal TN; Wills MR; Rosenkilde MM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection-induced inflammasome activation in human monocytes.
    Torii Y; Kawada JI; Murata T; Yoshiyama H; Kimura H; Ito Y
    PLoS One; 2017; 12(4):e0175053. PubMed ID: 28369146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells.
    Reinhart NM; Akinyemi IA; Frey TR; Xu H; Agudelo C; Brathwaite J; Burton EM; Burgula S; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Jan; 566():136-142. PubMed ID: 34922257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
    Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.
    Spiess K; Fares S; Sparre-Ulrich AH; Hilgenberg E; Jarvis MA; Ehlers B; Rosenkilde MM
    J Virol; 2015 Feb; 89(4):2253-67. PubMed ID: 25505061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.
    Zuo J; Currin A; Griffin BD; Shannon-Lowe C; Thomas WA; Ressing ME; Wiertz EJ; Rowe M
    PLoS Pathog; 2009 Jan; 5(1):e1000255. PubMed ID: 19119421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A promiscuous inflammasome sparks replication of a common tumor virus.
    Burton EM; Goldbach-Mansky R; Bhaduri-McIntosh S
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1722-1730. PubMed ID: 31919284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle.
    Long X; Yang J; Zhang X; Yang Z; Li Y; Wang F; Li X; Kuang E
    EMBO Rep; 2021 Jan; 22(1):e50714. PubMed ID: 33225563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase.
    Beisser PS; Verzijl D; Gruijthuijsen YK; Beuken E; Smit MJ; Leurs R; Bruggeman CA; Vink C
    J Virol; 2005 Jan; 79(1):441-9. PubMed ID: 15596837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1.
    Tsutsumi N; Qu Q; Mavri M; Baggesen MS; Maeda S; Waghray D; Berg C; Kobilka BK; Rosenkilde MM; Skiniotis G; Garcia KC
    Immunity; 2021 Jul; 54(7):1405-1416.e7. PubMed ID: 34216564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor.
    Paulsen SJ; Rosenkilde MM; Eugen-Olsen J; Kledal TN
    J Virol; 2005 Jan; 79(1):536-46. PubMed ID: 15596846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 upregulates ICAM-1 through a mechanism involving the NF-қB pathway.
    Guo Q; Gao J; Cheng L; Yang X; Li F; Jiang G
    Biosci Biotechnol Biochem; 2020 Sep; 84(9):1810-1819. PubMed ID: 32567483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation.
    Lee S; Kim J; Chung WC; Han JH; Song MJ
    J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation.
    Borde C; Escargueil AE; Maréchal V
    Antiviral Res; 2023 Sep; 217():105699. PubMed ID: 37549849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality.
    Mavri M; Kubale V; Depledge DP; Zuo J; Huang CA; Breuer J; Vrecl M; Jarvis MA; Jovičić EJ; Petan T; Ehlers B; Rosenkilde MM; Spiess K
    Front Endocrinol (Lausanne); 2022; 13():862940. PubMed ID: 35721730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Evasion by Epstein-Barr Virus.
    Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
    Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus Envelope Glycoprotein gp110 Inhibits IKKi-Mediated Activation of NF-κB and Promotes the Degradation of β-Catenin.
    Guo Y; Pan L; Wang L; Wang S; Fu J; Luo W; Wang K; Li X; Huang C; Liu Y; Kang H; Zeng Q; Fu X; Huang Z; Li W; He Y; Li L; Peng T; Yang H; Li M; Xiao B; Cai M
    Microbiol Spectr; 2023 Jun; 11(3):e0032623. PubMed ID: 37022262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1.
    Knerr JM; Kledal TN; Rosenkilde MM
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.